Imagine a future where indoor wireless communication systems handle skyrocketing data demands and do so with unmatched ...

In recent trading, Lightwave Logic Inc (LWLG) stock price has shown some volatility, fluctuating 8.55% over the last five trades and 11.88% over the past 30 trades. This represents a notable shift ...

Led by singer-guitarist Pall Jenkins, Mr. Tube & the Flying Objects specializes in soundtrack-y songs that seem to hail from the ‘60s or ‘70s, except filtered through an experimental R&B-flavored ...

The phase II LIGHTWAVE study evaluating Sage Therapeutics' dalzanemdor for treating cognitive issues due to Alzheimer's disease fails to meet the primary goal.

Sage Therapeutics’ share price fell 11% to $6 in pre-market activity on Tuesday, after it announced disappointing top-line ...

The global photonic crystal displays market is anticipated to reach US$ 114946.4 million by 2032, based on the most recent data available from Future Market Insights’ market analysis of photonic ...

The Federal Reserve’s recent half-point rate cut is expected to benefit small-cap stocks more than large-caps due to their ...

Sage Therapeutics has said it will stop the development of dalzanemdor in Alzheimer's disease, a few months after pulling the ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

Prolia® (denosumab) is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal womenTVB-009P, Teva's proposed biosimilar to Prolia, showed ...

(RTTNews) - Sage Therapeutics, Inc. (SAGE) Tuesday said its Phase 2 LIGHTWAVE study to evaluate dalzanemdor in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's ...

Sage Therapeutics shares fell as much as 25% in premarket trading after the company announced disappointing topline results ...